- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02374138
Breathe With Ease: A Unique Approach to Managing Stress (BEAMS)
Improving Asthma Outcomes Through Stress Management
Uncontrolled asthma in at-risk youth responds well to guideline-based therapy when patients remain adherent to their management plans. Adherence to inhaled corticosteroids (ICS), when indicated for persistent or uncontrolled asthma, is a critical component of most asthma management plans, and other self-management practices such as trigger avoidance are similarly related to improved asthma outcomes. Adherence to self-management practices is mediated by multiple factors, including psychosocial stress of parents and their children.
A targeted, culturally appropriate intervention to manage psychosocial stress among the parents of young, African American, and socioeconomically disadvantaged urban children with asthma who are receiving guideline-based care may improve asthma self-management, and therefore asthma outcomes.
Our overall aim is to implement and evaluate a highly collaborative, multi-dimensional, culturally appropriate and community-based asthma intervention to augment existing guideline-based best practice. The intervention will target the parents of at-risk, urban, African American youth, and will employ individualized psychosocial stress management and peer support.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Uncontrolled asthma in at-risk youth responds well to guideline-based therapy when patients remain adherent to their management plans. Adherence to inhaled corticosteroids (ICS), when indicated for persistent or uncontrolled asthma, is a critical component of most asthma management plans, and other self-management practices such as trigger avoidance are similarly related to improved asthma outcomes. Adherence to self-management practices is mediated by multiple factors, including psychosocial stress of parents and their children.
A targeted, culturally appropriate intervention to manage psychosocial stress among the parents of young, African American, and socioeconomically disadvantaged urban children with asthma who are receiving guideline-based care may improve asthma self-management, and therefore asthma outcomes.
Our overall aim is to implement and evaluate a highly collaborative, multi-dimensional, culturally appropriate and community-based asthma intervention to augment existing guideline-based best practice. The intervention will target the parents of at-risk, urban, African American youth, and will employ individualized psychosocial stress management and peer support.
We will conduct a single blind, prospective randomized controlled trial comparing the IMPACT DC Asthma Clinic's existing intervention of guideline-based clinical care, education, and short-term care coordination (usual care) to usual care plus parental stress management in a cohort of up to 200 parent-child dyads of AA youth aged 4-12 years.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
District of Columbia
-
Washington, District of Columbia, États-Unis, 20010
- Children's National Medical Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
We plan to enroll parent-child dyads that meet the following criteria:
Inclusion criteria (Parent):
- self-identify as African-American
- both the legal guardian and primary asthma caregiver of an eligible child.
Exclusion criteria (Parent):
- unable or unwilling to sign informed consent document
- exclusionary psychiatric condition, including but not limited to psychosis, based on the screening form at recruitment
- enrolled in another asthma research study.
Inclusion criteria (Child):
- parent-identified as African-American
- age 4-12 years inclusive at recruitment
- physician diagnosis of persistent asthma
- publicly financed insurance
Exclusion criteria (Child):
- chronic medical condition (other than asthma) including but not limited to diabetes, sickle cell disease, heart disease, lung disease or neurological disorder.
In addition, the PI may choose to not include a participant if he does not believe it is in the family's best interest to participate.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Usual Care
IMPACT DC Asthma Clinic intervention of guideline-based clinical care, education, and short-term care coordination
|
IMPACT DC Asthma Clinic intervention of guideline-based clinical care, education, and short-term care coordination
|
|
Expérimental: Intervention
Parental stress management in addition to IMPACT DC intervention of guideline-based clinical care, education, and short-term care coordination.
|
The intervention for this study is a multi-dimensional stress management program designed to be responsive to parent and other stakeholder preferences.
The intervention will have two separate yet coordinated components: one-on-one stress management sessions and peer group sessions led by "community wellness coaches."
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Symptom-free Days in the Last 14 Days
Délai: Repeated Measures at 6 months (3 month data collected to allow for repeated measures)
|
Symptom-free days are defined as a 24-hour period with no coughing, wheezing, chest tightness, or shortness of breath and no need for rescue medications
|
Repeated Measures at 6 months (3 month data collected to allow for repeated measures)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Asthma Morbidity - Nighttime Asthma Symptoms
Délai: Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
Nights of asthma symptoms in prior 14d
|
Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
|
Asthma Severity and Control
Délai: Repeated Measures at 3, 6, and 12 months
|
Repeated Measures at 3, 6, and 12 months
|
|
|
Asthma Medication Adherence
Délai: Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
Reported use of inhaled corticosteroids and LTRA in past two days
|
Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
|
Health Care Utilization - Emergency Department Visits for Asthma
Délai: 12 months after enrollment
|
Health care utilization - emergency department visits for asthma over six month and twelve month follow up periods.
Reported as those documented in the electronic medical record of Children's National Health System plus parent report of visits elsewhere
|
12 months after enrollment
|
|
Asthma Exacerbations - Courses of Systemic Steroids
Délai: Assessed at 6m and 12m following enrollment
|
Courses of systemic steroids over 12m follow up period
|
Assessed at 6m and 12m following enrollment
|
|
Parental Stress
Délai: Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
Score on Perceived Stress Scale (PSS).
The Perceived Stress Scale consists of 10 questions and is a measure of the degree to which situations in one's life are appraised as stressful.
Scores range from 0 - 40, with higher scores indicating a higher level of perceived stress.
|
Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
|
Parental Depression
Délai: Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
Score on Center for Epidemiologic Studies Depression Scale (CES-D - 10).
The CESD-10 scale screens for depressive symptoms.
Scores range from 0-30, with higher scores indicating a higher degree of depressive symptoms.
|
Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
|
Child Anxiety
Délai: Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
PROMIS Parent Proxy Anxiety.
For PROMIS instruments, T-scores rescale the raw score into a standardized score with a mean of 50 and a standard deviation of 10.
A higher T-score represents higher anxiety and/or depression.
|
Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
|
Child Depression
Délai: Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
PROMIS Parent Proxy Depressive Symptoms is a parent-report assessment of child depression.
For PROMIS instruments, T-scores rescale the raw score into a standardized score with a mean of 50 and a standard deviation of 10.
A higher T-score represents higher anxiety and/or depression.
|
Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
|
Caregiver Quality of Life
Délai: Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
Caregiver quality of life score, assessed by modified Pediatric Asthma Caregiver Quality of Life Questionnaire (PACQLQ).
The measure had five response options, with scores ranging from 13-65 and higher scores meaning better quality of life.
No subscales were analyzed.
|
Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
|
Number of Participants With AEs and SAEs
Délai: 12m follow up period
|
Safety data: Number of Participants with AEs and SAEs
|
12m follow up period
|
|
Economic Outcomes
Délai: 12m follow-up period
|
Analysis of costs of care in both groups
|
12m follow-up period
|
|
Caregiver Smoking Behavior
Délai: Repeated Measures at 6 and 12 months
|
parent report of cigarettes smoked per day
|
Repeated Measures at 6 and 12 months
|
|
Coping Strategies
Délai: Repeated measures at 12m FU (6m data used for repeated measures)
|
Brief COPE
|
Repeated measures at 12m FU (6m data used for repeated measures)
|
|
Mindfulness
Délai: Repeated Measures at 6 and 12 months
|
Interpersonal Mindfulness in Parenting
|
Repeated Measures at 6 and 12 months
|
|
Parental Resilience
Délai: Repeated Measures at 6 and 12 months
|
Parental resilience assessed by score on Revised Life Orientation Test (LOT-R) measure.
The LOT-R assesses optimism/resilience, and is comprised of 10 questions.
Scores range from 0-40, with a higher score indicating a higher level of optimism.
|
Repeated Measures at 6 and 12 months
|
|
Exacerbations - Hospital Admissions
Délai: Assessed at 6m and 12m after enrollment
|
Number of participants with hospital admissions due to exacerbations
|
Assessed at 6m and 12m after enrollment
|
|
Symptom-free Days in the Last 14 Days
Délai: Repeated Measures at 12 months (with data also assessed at 3m and 6m)
|
Symptom-free days are defined as a 24-hour period with no coughing, wheezing, chest tightness, or shortness of breath and no need for rescue medications
|
Repeated Measures at 12 months (with data also assessed at 3m and 6m)
|
|
Asthma Morbidity - Daytime Asthma Symptoms, Days of Activity Limitations, and Days of Quick Relief Medicine Use
Délai: Repeated measures at 6 and 12 months (3m data collected for repeated measures)
|
Days of asthma symptoms, activity limitation, and quick relief medicine use in prior 14d
|
Repeated measures at 6 and 12 months (3m data collected for repeated measures)
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Sociodemographics
Délai: Baseline
|
Age, gender, race, ethnicity, insurance type, parental education, household income, family medical history
|
Baseline
|
|
Number of Participants With Positive Smoke Exposure
Délai: Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
Participants with environmental smoke exposure.
Responses were regrouped as negative (none) or positive (daily, often, or rarely) based on two questions: "How often did anyone smoke inside the home where child usually lives?" or "How often did anyone smoke in the room where child usually sleeps?"
A positive response on either or both questions was considered positive exposure.
|
Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
|
|
Parental Health Literacy
Délai: Baseline
|
Single Item Literacy Screener (SILS)
|
Baseline
|
|
Use of Existing Ancillary Services
Délai: Assessed at 6m and 12m following enrollment
|
Assessed at 6m and 12m following enrollment
|
|
|
Parental Resilience
Délai: Baseline
|
Parental resilience assessed by score on Revised Life Orientation Test (LOT-R) measure.
The LOT-R assesses optimism/resilience, and is comprised of 10 questions.
Scores range from 0-40, with a higher score indicating a higher level of optimism.
|
Baseline
|
|
Intervention Component Uptake
Délai: 6 month intervention period
|
Completion of intervention sessions
|
6 month intervention period
|
|
Intervention Satisfaction
Délai: 6 month intervention period
|
Brief survey of satisfaction with intervention components.
|
6 month intervention period
|
|
Intervention Fidelity
Délai: 6 month intervention period
|
Checklist of staff's fidelity to individual components of intervention protocol
|
6 month intervention period
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Stephen Teach, MD, MPH, Children's National Health System
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 5819
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .